- Published: July 2012
- Region: Asia
Global Vitamin D Testing Market 2014-2018
- ID: 2686213
- October 2013
- Region: Global
- 65 Pages
The analysts forecast the Global Vitamin D Testing Market to grow at a CAGR of 32.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in aging and chronically ill populations worldwide. The Global Vitamin D Testing Market has also been witnessing the increase in product approvals. However, the stringent regulatory requirements could pose a challenge to the growth of this market.
The report, the Global Vitamin D Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Vitamin D Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Abbott Laboratories, DiaSorin S.p.A., Immunodiagnostic Systems Holdings plc, Roche Holding AG, and Siemens Healthcare Diagnostics Inc.
Other vendors mentioned in the report are DIAsource ImmunoAssays S.A., Gold Standard Diagnostics Corp., Ortho Clinical Diagnostics Inc., Qualigen Inc., Quest Diagnostics Inc., and Tosoh Bioscience Inc.
Key questions answered in this report:
- What will the market size be in 2016/2018 and what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast by Revenue
06.3 Market Size and Forecast by Volume
06.4 Vitamin D Testing Market in the US
06.4.1 Market Size and Forecast by Volume
06.5 Vitamin D Testing Market in Europe
06.5.1 Market Size and Forecast by Volume
06.6 Vitamin D Test Range Guidelines
06.7 Recommended Daily Intakes of Vitamin D
06.8 Upper Limits of Vitamin D Intakes
06.9 Consequences of Vitamin D Deficiency
06.10 Five Forces Analysis
07. Market Segmentation by Category
07.1 Segmentation of Global Vitamin D Testing Market by Category
07.1.1 25-hydroxy Vitamin D Test
07.1.2 1,25-dihydroxy Vitamin D Test
08. Market Segmentation by Types of Method
08.1.2 Direct Detection Methods
09. Market Segmentation by End-users
09.1 Global Vitamin D Testing Market Segmentation by End-users
10. Geographical Segmentation
10.1 Global Vitamin D Testing Market by Geographical Segmentation 24
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 DiaSorin S.p.A.
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Key Information
19.2.4 SWOT Analysis
19.3 Immunodiagnostic Systems Holdings plc
19.3.1 Business Overview
19.3.2 Key Information
19.3.3 SWOT Analysis
19.4 Roche Holding AG
19.4.1 Business Overview
19.4.2 Business Segmentation
19.4.3 Key Information
19.4.4 SWOT Analysis
19.5 Siemens Healthcare Diagnostics Inc.
19.5.1 Business Overview
19.5.2 Key Information
19.5.3 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Vitamin D Testing Market Segmentation
Exhibit 3: Global Vitamin D Testing Market 2013-2018 (US$ million)
Exhibit 4: Global Vitamin D Testing Market 2013-2018 (tests in million)
Exhibit 5: Vitamin D Testing Market in the US 2013-2018 (tests in million)
Exhibit 6: Vitamin D Testing Market in Europe 2013-2018 (tests in million)
Exhibit 7: Global Vitamin D Testing Market Segmentation by Category
Exhibit 8: Global Vitamin D Testing Market Segmentation by Category 2013
Exhibit 9: Global Vitamin D Testing Market Segmentation by Types of Method
Exhibit 10: Global Vitamin D Testing Market Segmentation by End-users
Exhibit 11: Global Vitamin D Testing Market Segmentation by End-users 2013
Exhibit 12: Global Vitamin D Testing Market by Geographical Segmentation 2013
Exhibit 13: Business Segmentation of Abbott Laboratories
Exhibit 14: Business Segmentation of DiaSorin S.p.A.
Exhibit 15: Business Segmentation of Roche Holding AG
Commenting on the report, an analyst from the team said: “The Global Vitamin D Testing market is experiencing a significant increase in approvals of the products of the leading vendors. For instance, Qualigen Inc. received the FDA approval for FastPack Vitamin D Immunoassay for use on its proprietary FastPack System for the rapid determination of vitamin D status, and Gold Standard Diagnostics Corp. obtained the FDA clearance for its 25-OH Vitamin D Total ELISA test in July 2013. Moreover, DiaSorin received the FDA clearance for its newly developed LIAISON 25 OH Vitamin D TOTAL assay in February 2012. Thus, these product approvals will have a positive impact on the growth of the market.”
According to the report,one of the major drivers is the increase in the aging and chronically ill populations worldwide. Moreover, as a result of the changes in lifestyle and food habits, the majority of the population is prone to several diseases. This increases the demand for various diagnostic procedures, including vitamin D testing. Presently, vitamin D deficiency is associated with several diseases such as cancer, diabetes, heart attack, and depression.
Further, the report states that one of the major challenges is the stringent regulatory approval process for vitamin D testing devices, thus leading to delayed approval of devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- Abbott Laboratories
- DiaSorin S.p.A.
- Immunodiagnostic Systems Holdings plc
- Roche Holding AG
- Siemens Healthcare Diagnostics Inc.
- DIAsource ImmunoAssays S.A.
- Gold Standard Diagnostics Corp.
- Ortho Clinical Diagnostics Inc.
- Qualigen Inc.
- Quest Diagnostics Inc.
- Tosoh Bioscience Inc.